TerrAscend Corp.
For the period ended Sep 30, 2026. Filed Nov 5, 2026.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Sep 30, 2026 · Filed Nov 5, 2026
What changed in Management’s Discussion and Analysis?
Read the current filingPrevious report: 10-Q
Period ended 2026-06-30; filed 2026-08-06.
0001193125-26-337940
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of OperationsCurrent report: 10-Q
Period ended 2026-09-30; filed 2026-11-05.
0001193125-26-449749
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of OperationsThe baseline is this issuer’s latest earlier reporting period of the same form that was filed before the current report. A previous 10-Q is a different quarter, not a year-over-year comparison. Amendments are excluded.
Compared 145 previous paragraphs and 147 current paragraphs.
88 unchanged; 41 reworded; 15 added; 16 removed; 0 previous and 3 current paragraphs rearranged.
Tables are not compared: 23 previous and 24 current tables excluded. Dates, whitespace, punctuation and numbering changes are ignored; changes to financial figures remain significant.
A changed paragraph is not evidence that risk increased or decreased. An unchanged paragraph does not establish that risk stayed the same.
Added paragraphs (15)
Current report
On August 24, 2026, the Company’s shareholders approved a special resolution amending the Company’s articles to consolidate the Common Shares, Non-Voting Shares, and preferred shares at a ratio of one post-consolidation share for every five to twenty pre-consolidation shares, with the exact whole-number ratio to be determined by the Board, at any time prior to August 24, 2027.
Current report
Any fractional shares will be cancelled for no consideration. As of the date of this Quarterly Report on Form 10-Q, the Board has not set the consolidation ratio and the consolidation has not been effected.
Current report
On August 20, 2026, the Board approved the renewal and replenishment of the Company’s share repurchase program, authorizing the repurchase of up to the lesser of 10,000,000 Common Shares or $10,000 of Common Shares from August 24, 2026 to August 23, 2027.
Current report
Cost of sales increased by $1,360, from $31,176 for the three months ended September 30, 2025 to $32,536 for the three months ended September 30, 2026. The increase was primarily driven by gross margin compression in New Jersey due to increased competition. The increase was partially offset by improved efficiencies following the expanded cultivation capacity in Pennsylvania.
Current report
The increase of $2,681 in general and administrative expense for the three months ended September 30, 2026 as compared to the three months ended September 30, 2025, was primarily attributable to transaction costs expensed in connection with the conversion option associated with the issuance of the 2026 Private Placement Convertible Debentures, as well as acquisition-related professional fees associated with the acquisition of Aunt Mary's, and operational expenses related to the acquisition of Union Chill Cannabis Company LLC ("Union Chill"). This increase was partially offset by a timing difference in the issuance of share-based compensation for the Board as compared to the prior period.
Current report
Finance and other expenses remained relatively flat for the three months ended September 30, 2026 compared to the three months ended September 30, 2025.
Current report
Loss from discontinued operations for the three months ended September 30, 2025 was primarily due to a $6,312 impairment charge attributable to subsequent offers from market participants, with the remainder primarily due to the termination of certain leases and inventory impairments.
Current report
Results of Operations - Nine Months Ended September 30, 2026 and September 30, 2025
Current report
Cost of sales increased by $1,774, from $92,568 for the nine months ended September 30, 2025 to $94,342 for the nine months ended September 30, 2026. The increase was primarily driven by gross margin compression in New Jersey due to increased competition. The increase was partially offset by improved efficiencies following the expanded cultivation capacity in Pennsylvania.
Current report
The cost of sales as a % of revenue was relatively flat for the nine months ended September 30, 2026 compared to the nine months ended September 30, 2025.
Current report
The increase of $4,901 in general and administrative expense for the nine months ended September 30, 2026 as compared to the nine months ended September 30, 2025, was primarily attributable to transaction costs expensed in connection with the conversion option associated with the issuance of the 2026 Private Placement Convertible Debentures, as well as acquisition-related professional fees associated with the acquisition of Aunt Mary's and operational expenses related to the acquisition of Union Chill.
Current report
Finance and other expenses remained relatively flat for the nine months ended September 30, 2026 compared to the nine months ended September 30, 2025.
Current report
Aunt Mary's Convertible Promissory Note
Current report
Represents the loss on extinguishment of debt recorded as a result of the extinguishment of the loans.
Removed paragraphs (16)
Previous report
On May 6, 2026, the Court entered an order appointing a Receiver over the Michigan Receivership Entities.
Previous report
On May 1, 2026, the Company and its subsidiaries party to the Loan Agreement, certain lender parties to the FG Loan Agreement and the Agent (as defined below) entered into a Forbearance Agreement as a result of the Michigan Receivership.
Previous report
Effective April 27, 2026, the Company appointed Eric Jackson as Chief Financial Officer.
Previous report
On April 23, 2026, the Acting Attorney General issued a Final Order reclassifying cannabis for medical use from Schedule I to Schedule III under the Controlled Substances Act. The order does not apply to adult-use cannabis which remains classified as a Schedule I controlled substance. The Final Order, effective as published in the Federal Register on April 28, 2026, establishes an expedited registration process for state medical licensees and indicates that registered state medical licensees would no longer be subject to Section 280E of the Internal Revenue Code following the effective date of the order. Additionally, the Order recommends to the Secretary of the Treasury that retrospective 280E relief be granted to licensees in line with their state license start dates. Separately, the Attorney General withdrew the pending hearing related to the proposed rulemaking notice issued in 2024 and instituted a new expedited hearing process starting on June 29, 2026 addressing both medical and adult-use cannabis, which concluded on July 15, 2026. The IRS has publicly indicated that, for Section 280E purposes, forthcoming guidance regarding the impact of rescheduling may include a transition rule allowing rescheduling relief to apply beginning with the taxable year that includes the effective date of the Final Order for activities no longer involving Schedule I or II substances; however, formal IRS guidance has not been issued yet. The ultimate impact of these developments, including the potential impact on previously recorded uncertain tax positions, remains uncertain and subject to ongoing evaluation due to the complexity of the evolving regulatory and tax environment. Accordingly, the Company is continuing to assess the potential financial statement impacts and is unable to reasonably estimate the ultimate effect at this time.
Previous report
Subsequent Transactions
Previous report
Cost of sales decreased by $902, from $31,771 for the three months ended June 30, 2025 to $30,869 for the three months ended June 30, 2026. The decrease was primarily due to decreases of $592 and $996 in Pennsylvania and Maryland, respectively, driven by improved verticality and facility utilization. The decrease was partially offset by an increase of $414 in New Jersey. The remaining decrease was attributable to all other segments.
Previous report
The decrease in cost of sales as a percentage of revenue is mainly due to reduced unit cost and improved cost absorption.
Previous report
The increase of $1,872 in general and administrative expense for the three months ended June 30, 2026 as compared to the three months ended June 30, 2025, was primarily due to operational expenses related to Company's acquisition of Union Chill Cannabis Company LLC ("Union Chill") and an increase in the provision for expected credit losses.
Previous report
Finance and other expenses for the three months ended June 30, 2026 as compared to the three months ended June 30, 2025, was relatively flat.
Previous report
Loss (gain) on fair value of derivative liabilities
Previous report
Results of Operations - Six Months Ended June 30, 2026 and June 30, 2025
Previous report
Cost of sales for the six months ended June 30, 2026 as compared to the six months ended June 30, 2025, was relatively flat due to a decrease in cost of sales in New Jersey which was offset by an increase in cost of sales in Pennsylvania and Maryland.
Previous report
The increase of $2,220 in general and administrative expense for the six months ended June 30, 2026 as compared to the six months ended June 30, 2025, was primarily due to operational expenses related to the Ratio Cannabis, LLC and Union Chill acquisitions and an increase in the provision for expected credit losses.
Previous report
The increase of $1,053 in finance and other expenses for the six months ended June 30, 2026 as compared to the six months ended June 30, 2025, was primarily due to an increase of interest and accretion related to the FG Loan.
Previous report
Gain on fair value of derivative liabilities
Previous report
Discontinued operations for the six months ended June 30, 2026 and 2025, reflected similar trends to the three month ended periods.
Reworded paragraphs (41)
Previous wording
This Management’s Discussion and Analysis (“MD&A”) of the financial condition and results of operations of the Company is for the three and six months ended June 30, 2026 and 2025 and the accompanying notes for each respective period.
Current wording
This Management’s Discussion and Analysis (“MD&A”) of the financial condition and results of operations of the Company is for the three and nine months ended September 30, 2026 and 2025.
Previous wording
TerrAscend New Jersey (“TerrAscend NJ”), a majority-owned operation with four dispensaries, and a cultivation/processing facility;
Current wording
TerrAscend New Jersey (“TerrAscend NJ”), a majority-owned operation with five dispensaries, and a cultivation/processing facility;
Previous wording
On June 12, 2026, the Company signed an option agreement to acquire equity interests in, and fully operate, Aunt Mary's Dispensary LLC, a dispensary in New Jersey for total consideration of $9,000, which will be comprised of $3,000 in the form of a five-year unsecured convertible promissory note bearing interest at 6.0% for an option to purchase 35% of Aunt Mary’s (“Option”) and $6,000 payable in cash upon exercise of the Option. The transaction is subject to customary closing conditions and regulatory approvals.
Current wording
On September 16, 2026, the Company acquired an option to purchase a 35% interest in Aunt Mary’s Dispensary LLC (“Aunt Mary’s”), which it exercised on September 23, 2026, and a transferable option to acquire the remaining 65% interest, for total consideration of $9,000, comprised of $6,000 in cash and $3,000 in the form of a five-year unsecured convertible promissory note bearing interest at 6.0% per annum (the "Aunt Mary’s Transaction"). The Aunt Mary’s Transaction conforms to New Jersey's regulatory framework, which facilitates investment opportunities for diversely owned businesses.
Previous wording
On June 23 and June 30, 2026, the Company entered into subscription agreements with certain accredited investors (the “Debenture Subscription Agreements”) in connection with a private placement offering of secured convertible debentures of the Company (the “2026 Private Placement Convertible Debentures”) and closed the initial issuance and sale of 21,835 debentures at a purchase price of $1,000 per debenture (the “Debenture Offering”). The Company used $11,124 of the proceeds from the Debenture Offering to retire the Company’s existing senior unsecured convertible debentures that matured on June 23, 2026, with the remaining portion of the gross proceeds available for mergers and acquisitions, and the repayment or refinancing of indebtedness. The 2026 Private Placement Convertible Debentures mature on September 30, 2031. In connection with the Debenture Offering, the Company entered into Amendment No. 5 to the FG Loan Agreement (as defined below), which, among other things, permitted the Debenture Offering.
Current wording
On June 23, June 30, and August 2, 2026, the Company entered into subscription agreements with certain accredited investors (the “Debenture Subscription Agreements”) in connection with a private placement offering of secured convertible debentures of the Company (the “2026 Private Placement Convertible Debentures”) and closed on the issuance and sale of an aggregate of 22,169 debentures at a purchase price of $1,000 per debenture (the “Debenture Offering”). The Company used $11,124 of the proceeds from the Debenture Offering to retire the Company’s existing senior unsecured convertible debentures that matured on June 23, June 30, and August 2, 2026, with the remaining portion of the gross proceeds available for mergers and acquisitions, and the repayment or refinancing of indebtedness. The 2026 Private Placement Convertible Debentures mature on September 30, 2031. In connection with the Debenture Offering, the Company entered into Amendment No. 5 to the FG Loan Agreement (as defined below), which, among other things, permitted the Debenture Offering.
Previous wording
Unrealized and realized foreign exchange loss
Current wording
Unrealized and realized foreign exchange loss (gain)
Previous wording
Unrealized and realized foreign exchange (gain) loss represents the loss recognized on the remeasurement of U.S. dollar ("USD") denominated cash and other assets recorded in the Canadian dollars ("CAD") functional currency at the Company's Canadian operations.
Current wording
Unrealized and realized foreign exchange loss (gain) represents the loss (gain) recognized on the remeasurement of U.S. dollar ("USD") denominated cash and other assets recorded in the Canadian dollars ("CAD") functional currency at the Company's Canadian operations.
Previous wording
Revenue increased by $2,113, from $65,006 for the three months ended June 30, 2025 to $67,119 for the three months ended June 30, 2026. The increase was primarily attributable to Pennsylvania, where revenue increased $1,627 due to higher retail sales driven by increased customer foot traffic. In both New Jersey and Maryland, retail sales were substantially offset by wholesale sales, resulting in relatively consistent revenue compared to the prior-year period. The remaining increase was attributable to all other segments.
Current wording
Revenue increased by $3,109, from $65,101 for the three months ended September 30, 2025 to $68,210 for the three months ended September 30, 2026. The increase was primarily attributable to Pennsylvania, where revenue increased $2,684 due to higher retail sales driven by increased customer foot traffic along with an increase in wholesale sales driven by expanded cultivation capacity. New Jersey had an increase in retail sales due to acquisitive growth that was substantially offset by a decline in wholesale sales driven by increased competition. In Maryland, an increase in wholesale sales were substantially offset by a decrease in retail sales. Resulting in relatively consistent revenue compared to the prior-year period for New Jersey and Maryland. The remaining activity was attributable to all other segments.
Previous wording
The cost of sales as a % of revenue remained flat compared to the prior year.
Current wording
The cost of sales as a percentage of revenue was flat for the three months ended September 30, 2026 compared to the three months ended September 30, 2025.
Previous wording
The loss on derivative liabilities of $1,171 for the three months ended June 30, 2026 compared with a gain of $279 for the three months ended June 30, 2025, was primarily driven by changes in the Common Share price during the respective periods, which resulted in changes in the fair value of the Company's outstanding derivative liabilities.
Current wording
The gain on derivative liabilities of $4,809 for the three months ended September 30, 2026 compared with a loss of $723 for the three months ended September 30, 2025, was primarily driven by a decline in the Common Share price relative to the exercise prices of the conversion options, resulting in a decrease in the fair value of the derivative liabilities.
Previous wording
The provision for income taxes increased by $1,989 from $9,598 for the three months ended June 30, 2025 compared to $11,587 for the three months ended June 30, 2026 primarily driven by accrued interest and penalties related to the Company's uncertain tax position and higher relative gross profit margin.
Current wording
The provision for income taxes increased by $854 from $11,034 for the three months ended September 30, 2025 compared to $11,888 for the three months ended September 30, 2026 primarily driven by accrued interest and penalties related to the Company's uncertain tax position and higher relative gross profit margin.
Previous wording
The following tables represent the Company’s results of operations for the six months ended June 30, 2026 and 2025.
Current wording
The following tables represent the Company’s results of operations for the nine months ended September 30, 2026 and 2025.
Previous wording
Revenue increased by $3,349, from $129,309 for the six months ended June 30, 2025 to $132,658 for the six months ended June 30, 2026. The increase was primarily attributable to Pennsylvania, where revenue increased $3,642 due to higher retail sales driven by increased customer foot traffic. In New Jersey, Maryland, and all other segments, retail sales were substantially offset by wholesale sales, resulting in relatively consistent revenue compared to the prior-year period.
Current wording
Revenue increased by $6,458, from $194,410 for the nine months ended September 30, 2025 to $200,868 for the nine months ended September 30, 2026. The increase was primarily attributable to Pennsylvania, where revenue increased by $6,326 driven by higher retail sales resulting from increased customer foot traffic, as well as increased wholesale sales driven by expanded cultivation capacity. Revenue decreased in New Jersey by $1,742 primarily due to a decrease in wholesale sales of $10,223 due to increased competition which was substantially offset by an increase in retail sales of $8,481 primarily driven by the acquisitions of Union Chill and Aunt Mary's. Maryland retail sales were substantially offset by wholesale sales, resulting in relatively consistent revenue compared to the prior-year period. All other segments revenue increased by $1,874 primarily due to a full year of retail sales in Ohio.
Previous wording
The gain on derivative liabilities of $232 for the six months ended June 30, 2026 compared with a gain of $376 for the six months ended June 30, 2025, was primarily driven by the decrease in fair value of private placement convertible debentures that expired during the second quarter of 2026.
Current wording
The gain on derivative liabilities of $5,041 for the nine months ended September 30, 2026 compared with a loss of $347 for the nine months ended September 30, 2025, was primarily driven by a decline in the Common Share price relative to the exercise prices of the conversion options, resulting in a decrease in the fair value of the derivative liabilities.
Previous wording
The provision for income taxes increased by $1,732 from $20,105 for the six months ended June 30, 2025 compared to $21,837 for the six months ended June 30, 2026. This increase was primarily driven by accrued interest and penalties related to the Company's uncertain tax position and higher relative gross profit margin.
Current wording
The provision for income taxes increased by $2,586 from $31,139 for the nine months ended September 30, 2025 compared to $33,725 for the nine months ended September 30, 2026. This increase was primarily driven by accrued interest and penalties related to the Company's uncertain tax position and higher relative gross profit margin.
Previous wording
Income from discontinued operations for the three months ended June 30, 2026 primarily reflects the gain recognized in connection with the deconsolidation of the Michigan Receivership Entities following the appointment of the Receiver. In contrast, the loss from discontinued operations for the three months ended June 30, 2025 primarily reflects impairment charges and operating losses incurred prior to the classification of the Company's Michigan operations as discontinued operations.
Current wording
Income from discontinued operations for the nine months ended September 30, 2026 primarily reflects the gain recognized in connection with the deconsolidation of the Michigan Receivership Entities following the appointment of the Receiver. In contrast, the loss from discontinued operations for the nine months ended September 30, 2025 primarily reflects impairment charges of $41,271, as well as losses related to lease terminations and inventory write-offs.
Previous wording
As of June 30, 2026, the Company had $209,682 in principal outstanding under its loans payable, excluding any prepayment or exit fees, of which $6,570 is due in the next twelve months. The Company also had $31,085 in principal outstanding under its convertible debt, none of which is due within the next twelve months.
Current wording
As of September 30, 2026, the Company had $209,076 in principal outstanding under its loans payable, excluding any prepayment or exit fees, of which $6,390 is due in the next twelve months. The Company also had $34,169 in principal outstanding under its convertible debt, none of which is due within the next twelve months.
Previous wording
The Company has entered into leases for certain premises and offices for which it owes monthly lease payments. The Company has $58,703 in lease obligations. Of this amount, $4,383 of lease payments are due in the next twelve months.
Current wording
The Company has entered into leases for certain premises and offices for which it owes monthly lease payments. The Company has $59,764 in lease obligations. Of this amount, $4,564 of lease payments are due in the next twelve months.
Previous wording
As of June 30, 2026, the Company had accounts payable and accrued liabilities of $40,133 and corporate income taxes payable of $2,290.
Current wording
As of September 30, 2026, the Company had accounts payable and accrued liabilities of $33,945 and corporate income taxes payable of $3,570.
Previous wording
On May 1, 2026, the Company, the Borrowers, the Incremental Amendment Borrowers, certain lenders party to the FG Loan Agreement (constituting “Required Lenders” under the FG Loan Agreement) and the Agent entered into the Forbearance Agreement in relation to certain events of default that occurred or were anticipated under the FG Loan Agreement, resulting from the Michigan Receivership, (the “Specified Defaults”). Under the Forbearance Agreement, the Secured Parties (as defined in the Forbearance Agreement) agreed to conditionally waive the Specified Defaults and forbear from exercising default-related remedies during the period from the Forbearance Effective Date ending the earliest to occur of the termination of the receivership process and the occurrence of any event of default not otherwise specified in the Forbearance Agreement (the “Forbearance Period”). Upon the “Successful Exit” (as defined in the Forbearance Agreement) of the Michigan Receivership, all Specified Defaults (as defined below) will be deemed automatically and irrevocably waived by the Secured Parties.
Current wording
On May 1, 2026 (the "Forbearance Effective Date"), the Company, the Borrowers, the Incremental Amendment Borrowers, certain lenders party to the FG Loan Agreement (constituting “Required Lenders” under the FG Loan Agreement) and the Agent entered into a forbearance agreement (the "Forbearance Agreement") in relation to certain events of default that occurred or were anticipated under the FG Loan Agreement, resulting from the Michigan Receivership, (the “Specified Defaults”). Under the Forbearance Agreement, the Secured Parties (as defined in the Forbearance Agreement) agreed to conditionally waive the Specified Defaults and forbear from exercising default-related remedies during the period from the Forbearance Effective Date ending the earliest to occur of the termination of the receivership process and the occurrence of any event of default not otherwise specified in the Forbearance Agreement (the “Forbearance Period”). Upon the “Successful Exit” (as defined in the Forbearance Agreement) of the Michigan Receivership, all Specified Defaults will be deemed automatically and irrevocably waived by the Secured Parties.
Previous wording
During the six months ended June 30, 2026, the Company made aggregate prepayments of $15,590 on the FG Loan, including applicable 3% prepayment fees.
Current wording
During the nine months ended September 30, 2026, the Company made aggregate prepayments of $16,501 on the FG Loan, including applicable 3% prepayment fees.
Previous wording
In connection with the acquisition of Hempaid, LLC on June 30, 2023 ("Blue Ridge") the Company entered into a promissory note with Blue Ridge bearing interest at 7.0% with a maturity date of June 30, 2027.
Current wording
In connection with the acquisition of Hempaid, LLC on June 30, 2023 ("Blue Ridge") the Company entered into a promissory note with Blue Ridge bearing interest at 7.0% per annum, with a maturity date of June 30, 2027.
Previous wording
In connection with the acquisition of the assets of Ratio Cannabis, LLC on May 7, 2025 ("Ratio") the Company entered into a promissory note with Ratio bearing interest at 6.0% with a maturity date of May 7, 2027.
Current wording
In connection with the acquisition of the assets of Ratio Cannabis, LLC on May 7, 2025 ("Ratio") the Company entered into a promissory note with Ratio bearing interest at 6.0% per annum, with a maturity date of May 7, 2027.
Previous wording
On June 23 and June 30, 2026, the Company entered into subscription agreements with certain accredited investors (the “Debenture Subscription Agreements”) in connection with a private placement offering of secured convertible debentures of the Company (the “2026 Private Placement Convertible Debentures”) and closed the initial issuance and sale of 21,835 debentures at a purchase price of $1,000 per debenture (the “Debenture Offering”). The Company used $11,124 of the proceeds from the Debenture Offering to retire the Company’s existing senior unsecured convertible debentures that matured on June 23, 2026, with the remaining portion of the proceeds available for mergers and acquisitions, and the repayment or refinancing of indebtedness. The 2026 Private Placement Convertible Debentures mature on September 30, 2031 (the “Maturity Date”) and bear interest at a rate of 8.00% per annum, payable quarterly in arrears in cash, beginning on September 30, 2026. The Company may elect to pay all or any portion of such interest in kind by capitalizing the interest as additional principal (see Note 12 to the Consolidated Financial Statements). The 2026 Private Placement Convertible Debentures are convertible, in whole or in part, into Common Shares, at the option of the holder, at any time prior to the close of business on the last business day immediately preceding the Maturity Date, at a conversion price of $0.87 per Common Share. The 2026 Private Placement Convertible Debentures are secured by a second lien on certain assets of the U.S. business and also secured by certain personal property assets of TerrAscend USA, Inc. under a subordinated guaranty and security agreement.
Current wording
On June 23, June 30 and August 2, 2026, the Company entered into subscription agreements with certain accredited investors (the “Debenture Subscription Agreements”) in connection with a private placement offering of secured convertible debentures of the Company (the “2026 Private Placement Convertible Debentures”) and closed the issuance and sale of an aggregate of 22,169 debentures at a purchase price of $1,000 per debenture (the “Debenture Offering”). The Company used $11,124 of the proceeds from the Debenture Offering to retire the Company’s existing senior unsecured convertible debentures that matured on June 23, June 30, and August 2, 2026, with the remaining portion of the proceeds available for mergers and acquisitions, and the repayment or refinancing of indebtedness. The 2026 Private Placement Convertible Debentures mature on September 30, 2031 (the “Maturity Date”) and bear interest at a rate of 8.00% per annum, payable quarterly in arrears in cash, beginning on September 30, 2026. The Company may elect to pay all or any portion of such interest in kind by capitalizing the interest as additional principal (see Note 12 to the Consolidated Financial Statements). The 2026 Private Placement Convertible Debentures are convertible, in whole or in part, into Common Shares, at the option of the holder, at any time prior to the close of business on the last business day immediately preceding the Maturity Date, at a conversion price of $0.87 per Common Share. The 2026 Private Placement Convertible Debentures are secured by a second lien on certain assets of the U.S. business and also secured by certain personal property assets of TerrAscend USA, Inc. under a subordinated guaranty and security agreement.
Previous wording
On December 26, 2025, the Company issued a convertible promissory note for $9,000 in relation to the transaction with Union Chill. Unless repaid or converted earlier, the outstanding principal and interest shall be due and payable on December 26, 2029 (the "Convertible Note Maturity Date"). The convertible promissory note bears interest at the rate of 6.5% per annum payable in quarterly payments within five days following the first business day of each fiscal quarter. The convertible promissory note is convertible into Common Shares, at the option of the holder, at any time or times prior to the close of business on the last business day immediately preceding the Convertible Note Maturity Date, at a conversion price of $1.89 per Common Share.
Current wording
On December 26, 2025, the Company issued a convertible promissory note for $9,000 in relation to the transaction with Union Chill. Unless repaid or converted earlier, the outstanding principal and interest shall be due and payable on December 26, 2029 (the "Union Chill Convertible Note Maturity Date"). The convertible promissory note bears interest at the rate of 6.5% per annum payable in quarterly payments within five days following the first business day of each fiscal quarter. The convertible promissory note is convertible into Common Shares, at the option of the holder, at any time or times prior to the close of business on the last business day immediately preceding the Union Chill Convertible Note Maturity Date, at a conversion price of $1.89 per Common Share.
Previous wording
On August 20, 2025, the Board approved the Share Repurchase Program, which replaced the Original Program. The Share Repurchase Program authorizes the Company to repurchase up to 10,000,000 Common Shares of the Company at any time, or from time to time, from August 22, 2025 until August 21, 2026. The Share Repurchase Program authorizes the Company to repurchase up to 60,255 Common Shares daily, which represents 25% of the Company’s average daily trading volume on the TSX of 241,023 Common Shares. Any repurchases under the program may be made by means of open market transactions, negotiated block transactions, or otherwise, including pursuant to a repurchase plan administered in accordance with Rules 10b5-1 and 10b-18 under the Securities Exchange Act of 1934, as amended. The size and timing of any repurchases will depend on price, market and business conditions, and other factors.
Current wording
On August 20, 2026, the Board approved the Share Repurchase Program, which replaced the Previous Program. The Share Repurchase Program authorizes the Company to repurchase up to the lesser of 10,000,000 Common Shares or $10,000 of Common Shares at any time, or from time to time, from August 24, 2026 until August 23, 2027. The Share Repurchase Program authorizes the Company to repurchase up to 58,784 Common Shares daily, which represents 25% of the Company’s average daily trading volume on the TSX of 235,136 Common Shares. Any repurchases under the program may be made by means of open market transactions, negotiated block transactions, or otherwise, including pursuant to a repurchase plan administered in accordance with Rules 10b5-1 and 10b-18 under the Securities Exchange Act of 1934, as amended. The size and timing of any repurchases will depend on price, market and business conditions, and other factors.
Previous wording
During the second quarter of 2026, the Company repurchased 463,500 common shares under the Share Repurchase Program for total consideration of $311. As of June 30, 2026, the Company had a total of 9,346,500 Common Shares remaining that can be authorized for repurchase.
Current wording
During the third quarter of 2026, the Company repurchased 1,013,000 Common Shares under the Share Repurchase Program for total consideration of $634. As of September 30, 2026, the Company had a total of 9,357,000 Common Shares remaining available for repurchase under the Share Repurchase Program.
Previous wording
The decrease of $2,442 in net cash provided by operating activities for the six months ended June 30, 2026 compared to the six months ended June 30, 2025 was primarily driven by changes in net working capital, including increased inventory.
Current wording
The decrease of $734 in net cash provided by operating activities for the nine months ended September 30, 2026 compared to the nine months ended September 30, 2025 was primarily driven by changes in net working capital.
Previous wording
Net cash used in operating activities for the six months ended June 30, 2026 primarily relates to costs associated with the disposition of certain assets and liabilities and entering into the Michigan Receivership. In contrast, net cash used in operating activities for the six months ended June 30, 2025 was primarily driven by unfavorable changes in working capital.
Current wording
Net cash used in operating activities for the nine months ended September 30, 2026 primarily relates to costs associated with the disposition of certain assets and liabilities and entering into the Michigan Receivership. In contrast, net cash used in operating activities for the nine months ended September 30, 2025 was primarily driven by negative cash flows prior to the Company's plan to exit the Michigan market (the "Michigan Exit").
Previous wording
The decrease of $7,364 in net cash used in investing activities for the six months ended June 30, 2026 compared to the six months ended June 30, 2025 was primarily driven by a decrease of $2,146 for investments in capital expenditures. The change was also attributable to cash consideration, net of cash acquired of $3,722 paid in connection with the Union Chill acquisition, and a $3,400 refund of the deposit for a potential business acquisition.
Current wording
The decrease of $3,788 in net cash used in investing activities for the nine months ended September 30, 2026 compared to the nine months ended September 30, 2025 was primarily driven by a decrease of $1,705 for investments in capital expenditures, a $3,400 refund of an acquisition related deposit, and the collection of note receivable principal for $1,793. This was slightly offset by cash consideration, net of cash acquired of $3,552 and $5,203 paid in connection with the acquisition of Union Chill and Aunt Mary's, respectively.
Previous wording
The increase of $2,030 in net cash provided by (used in) investing activities for the six months ended June 30, 2026 compared to the six months ended June 30, 2025 was primarily driven by the sale of property and equipment related to the exit of Michigan.
Current wording
The increase of $2,170 in net cash provided by (used in) investing activities for the nine months ended September 30, 2026 compared to the nine months ended September 30, 2025 was primarily driven by the sale of property and equipment related to the Michigan Exit.
Previous wording
The increase of $8,550 in net cash used in financing activities for the six months ended June 30, 2026, compared to the six months ended June 30, 2025, was primarily attributable to higher loan principal paid, including exit fees, of $14,270, repayments of existing private placement convertible debentures of $8,630, and higher distributions to non-controlling interests during 2026. This was partially offset by $18,967 net of proceeds received from the issuance of the 2026 Private Placement Convertible Debentures. In contrast, financing activities during the prior-year period included $5,000 of loan proceeds, net of transaction costs.
Current wording
The increase of $21,317 in net cash used in financing activities for the nine months ended September 30, 2026, compared to the nine months ended September 30, 2025, was primarily attributable to higher net loan principal paid, including exit fees, of $16,524, repayments of existing private placement convertible debentures of $8,630, and higher distributions to non-controlling interests during 2026. This was partially offset by $18,967 net of proceeds received from the issuance of the 2026 Private Placement Convertible Debentures. In contrast, financing activities during the prior-year period included net loan proceeds of $12,813 slightly offset by distributions to non-controlling interests of $2,046.
Previous wording
The net cash used in financing activities for the six months ended June 30, 2026 was primarily driven by the finance lease termination fee paid.
Current wording
The net cash used in financing activities for the nine months ended September 30, 2026 was primarily driven by the finance lease termination fee paid.
Previous wording
In addition to reporting the financial results in accordance with GAAP, the Company reports certain financial results that differ from what is reported under GAAP. Non-GAAP measures used by management do not have any standardized meaning prescribed by GAAP and may not be comparable to similar measures presented by other companies. The Company believes that certain investors and analysts use these measures to measure a company’s ability to meet other payment obligations or as a common measurement to value companies in the cannabis industry, and the Company calculates: (i) Free cash flow from net cash provided by operating activities from continuing operations less capital expenditures for property and equipment which management believes is an important measurement of the Company's ability to generate additional cash from its business operations, and (ii) EBITDA from continuing operations and Adjusted EBITDA from continuing operations as net loss, adjusted to exclude provision for income taxes, finance expenses, depreciation and amortization, share-based compensation, unrealized and realized (gain) loss on investments, (gain) loss from revaluation of contingent consideration, unrealized and realized foreign exchange (gain) loss, loss (gain) on fair value of derivative liabilities, (gain) loss on lease terminations, and certain other items, which management believes is not reflective of the ongoing operations and performance of the Company. Such information is intended to provide additional information and should not be considered in isolation or as a substitute for measures of performance prepared in accordance with GAAP.
Current wording
In addition to reporting the financial results in accordance with GAAP, the Company reports certain financial results that differ from what is reported under GAAP. Non-GAAP measures used by management do not have any standardized meaning prescribed by GAAP and may not be comparable to similar measures presented by other companies. The Company believes that certain investors and analysts use these measures to measure a company’s ability to meet other payment obligations or as a common measurement to value companies in the cannabis industry, and the Company calculates: (i) Free cash flow from net cash provided by operating activities from continuing operations less capital expenditures for property and equipment which management believes is an important measurement of the Company's ability to generate additional cash from its business operations, and (ii) EBITDA from continuing operations and Adjusted EBITDA from continuing operations as net loss, adjusted to exclude provision for income taxes, finance expenses, depreciation and amortization, share-based compensation, unrealized and realized foreign exchange loss (gain), (gain) loss on lease terminations, (gain) loss on fair value of derivative liabilities, unrealized and realized loss on investments, Loss on extinguishment of debt, gain from revaluation of contingent consideration, , and certain other items, which management believes is not reflective of the ongoing operations and performance of the Company. Such information is intended to provide additional information and should not be considered in isolation or as a substitute for measures of performance prepared in accordance with GAAP.
Previous wording
The table below reconciles net loss to EBITDA from continuing operations and Adjusted EBITDA from continuing operations for the three and six months ended June 30, 2026 and 2025:
Current wording
The table below reconciles net loss to EBITDA from continuing operations and Adjusted EBITDA from continuing operations for the three and nine months ended September 30, 2026 and 2025:
Previous wording
Represents the gain recognized as a result of lease termination.
Current wording
Represents the (gain) loss recognized as a result of lease termination
Previous wording
Represents the gain on fair value of conversion options.
Current wording
Represents the (gain) loss on fair value of conversion options
Previous wording
Includes one-time items incurred primarily in connection with the Company's acquisitions and other costs considered one-time in nature, such as expenses related to professional, consulting, legal, and accounting fees. These fees are not indicative of the Company's ongoing costs.
Current wording
Includes one-time items incurred primarily in connection with the Company's acquisitions and other costs considered one-time in nature, such as expenses related to professional, consulting, legal, accounting fees, and lobbying expenses associated with specific legalization initiatives. These fees are not indicative of the Company's ongoing costs.
Previous wording
Adjusted EBITDA from continuing operations increased by $1,773 and $991 for the three and six months ended June 30, 2026 as compared to three and six months ended June 30, 2025, respectively. These increases were primarily driven by gross profit margin expansion.
Current wording
Adjusted EBITDA from continuing operations increased by $492 and $1,355 for the three and nine months ended September 30, 2026 as compared to three and nine months ended September 30, 2025, respectively. These increases were primarily driven by gross profit margin expansion.
Previous wording
The table below reconciles net cash provided by operating activities from continuing operations to free cash flow for the six months ended June 30, 2026 and 2025:
Current wording
The table below reconciles net cash provided by operating activities from continuing operations to free cash flow for the nine months ended September 30, 2026 and 2025:
Previous wording
The Company will remain an emerging growth company until the earlier to occur of: (i) December 31, 2027 (a) in which the Company has total annual gross revenue of $1,235,000 or more, or (b) in which the Company is deemed to be a large accelerated filer, which means the market value of the Company's Common Shares that are held by non-affiliates exceeds $700,000 as of the last business day of the Company’s most recent second fiscal quarter; and (ii) the date on which the Company has issued more than $1,000,000 in non-convertible debt during the prior three-year period.
Current wording
The Company will remain an emerging growth company until the earliest of: (i) December 31, 2027, (ii) the last day of the fiscal year in which the Company has total annual gross revenue of $1,235,000 or more, or (iii) the date on which the Company is deemed to be a large accelerated filer, which means the market value of the Company's Common Shares that are held by non-affiliates exceeds $700,000 as of the last business day of the Company’s most recent second fiscal quarter; and (iv) the date on which the Company has issued more than $1,000,000 in non-convertible debt during the prior three-year period.
Showing the first 40 of 41 pairs. Open the source sections for the rest.
Rearranged current paragraphs (3)
Current report — wording carried from elsewhere
(Gain) loss on fair value of derivative liabilities
Current report — wording carried from elsewhere
Gain (loss) on fair value of derivative liabilities
Current report — wording carried from elsewhere
On September 16, 2026, the Company issued a convertible promissory note for $3,000 in relation to the transaction with Aunt Mary’s. Unless repaid or converted earlier, the outstanding principal and interest shall be due and payable on September 15, 2031 (the "Aunt Mary’s Convertible Note Maturity Date"). The convertible promissory note bears interest at the rate of 6.0% per annum payable in quarterly payments within five days following the first business day of each fiscal quarter. The convertible promissory note is convertible into Common Shares, in intervals of at least $1, at the option of the holder, at any time or times prior to the close of business on the last business day immediately preceding the Aunt Mary’s Convertible Note Maturity Date, at a conversion price of $0.79 per Common Share.